Botulinum toxin type a treatment for Meige syndrome A case of blepharospasm combined with oromandibular dystonia and literature review
Annals of Case Reports and Medical Images · 31.12.2025 · 2 (2)
DOI: 10.52768/3065-7849/1049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Case Reports and Medical Images, online erschienen am 31.12.2025. Verfasst von Xiao Long.
Abstract (Originalsprache)
Meige Syndrome (MS) is characterized by blepharospasm and oromandibular dystonia that are often refractory to oral medications.
Zitieren
APA
Long, X. (2025). Botulinum toxin type a treatment for Meige syndrome A case of blepharospasm combined with oromandibular dystonia and literature review. Annals of Case Reports and Medical Images, 2(2). https://doi.org/10.52768/3065-7849/1049
Vancouver
Long X. Botulinum toxin type a treatment for Meige syndrome A case of blepharospasm combined with oromandibular dystonia and literature review. Annals of Case Reports and Medical Images. 2025;2(2). doi:10.52768/3065-7849/1049
BibTeX
@article{Long2025,
author = {Long, Xiao},
title = {Botulinum toxin type a treatment for Meige syndrome A case of blepharospasm combined with oromandibular dystonia and literature review},
journal = {Annals of Case Reports and Medical Images},
year = {2025},
volume = {2},
number = {2},
doi = {10.52768/3065-7849/1049}
}
EUVIMED